traffic information
|
weather
|
web feeds
| mobile
Silicon Valley
Site
Web Search by
YAHOO!
Home
News
Venture Capital
Personal Tech
The Valley
Hot Topics
Phones/Mobile
Social Networks
Green Energy
Security
Companies
Apple
Google
Facebook
Cisco Systems
Intel
Hewlett-Packard
Oracle
Yahoo
eBay
Gilead Sciences
Adobe Systems
Intuit
Netflix
Electronic Arts
Tesla Motors
Twitter
Zynga
SunPower
Solyndra
Kleiner Perkins
People
Steve Jobs
Larry Ellison
Eric Schmidt
Mark Zuckerberg
Carol Bartz
John Doerr
John Chambers
Paul Otellini
Vinod Khosla
Mark Andreessen
Ron Conway
Biz Stone
Elon Musk
Larry Page
Sergey Brin
Ann Livermore
Marissa Mayer
Sheryl Sandberg
T.J. Rodgers
Mark Hurd
columnists
gmsv
Special Reports
Venture Capital Survey
Salary Survey
Silicon Valley 150
Services
RSS Feeds
Mobile Edition
Widgets
Contact Us
Jobs
Advertising
Archives
Go to MercuryNews.com
Silicon Valley 150
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
ANACOR PHARM
(NQ:
ANAC
)
6.090
USD
-0.010 (-0.16%)
Official Closing Price
/ Updated:
8:10 PM EDT, May 17, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
6.110
Bid (Size)
6.100 (15700)
Ask (Size)
6.110 (900)
Prev. Close
6.100
Today's Range
5.980 - 6.190
52wk Range
3.000 - 8.250
Shares Outstanding
40,494,466
Dividend Yield
N/A
Top News
More News
Semi-Annual Changes to the NASDAQ Biotechnology Index
May 13, 2013
from
GlobeNewswire News Releases
Anacor Pharmaceuticals, Inc. (ANAC) Posts Q1 Loss of 42c/Share
May 09, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8324184 for the full story.
Read More
from
StreetInsider.com News Articles
More News
Read More
Anacor Pharmaceuticals Reports First Quarter 2013 Financial Results
May 09, 2013
from
Business Wire News Releases
Trading Radar for 05/09: priceline.com (PCLN), NVIDIA (NVDA), DISH Network (DISH), Dean Foods (DF) Report
May 08, 2013
from
StreetInsider.com News Articles
Anacor Pharmaceuticals Announces First Quarter 2013 Financial Results Conference Call and Webcast
May 07, 2013
from
Business Wire News Releases
Valeant Pharmaceuticals Agrees to Delay Efinconazole Launch
May 02, 2013
category
Management
,
Benzinga
,
Global
, and 5 more.
from
Latest Articles from Benzinga.com
Valeant Pharmaceuticals Provides Efinconazole Update
May 02, 2013
from
PR Newswire
Anacor Issues Update on Arbitration with Valeant, Says Prelim. Injunction Hearing Cancelled
May 02, 2013
category
Benzinga
,
ANAC
,
VRX
, and 2 more.
from
Latest Articles from Benzinga.com
Anacor Pharmaceuticals Provides Update Regarding Arbitration With Valeant Pharmaceuticals
May 02, 2013
from
Business Wire News Releases
Anacor Pharmaceuticals Announces Closing of $23M Public Offering of Common Stock, Including Full Exercise of Underwriters' Over-Allotment Option
May 01, 2013
category
Benzinga
,
ANAC
,
Offerings
, and 1 more.
from
Latest Articles from Benzinga.com
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
web feeds
